scispace - formally typeset
B

B. Villeret

Researcher at University of Orléans

Publications -  7
Citations -  474

B. Villeret is an academic researcher from University of Orléans. The author has contributed to research in topics: Idiopathic pulmonary fibrosis & Fibrosis. The author has an hindex of 4, co-authored 5 publications receiving 383 citations.

Papers
More filters
Journal ArticleDOI

ATP release and purinergic signaling: a common pathway for particle-mediated inflammasome activation.

TL;DR: It is shown that uric acid, silica and Alum crystals trigger the extracellular delivery of endogenous ATP, which just precedes the secretion of mature interleukin-1β by macrophages, both events depending on purinergic receptors and connexin/pannexin channels.
Journal ArticleDOI

The NLRP3 inflammasome is activated by nanoparticles through ATP, ADP and adenosine

TL;DR: It is shown for the first time that extracellularAdenosine activates the NLRP3 inflammasome by two ways: by interacting with adenosine receptors at nanomolar/micromolar concentrations and through cellular uptake by equilibrative nucleoside transporters at millimolar concentrations.
Journal ArticleDOI

Discordance in cathepsin B and cystatin C expressions in bronchoalveolar fluids between murine bleomycin-induced fibrosis and human idiopathic fibrosis

TL;DR: The activity of cysteine cathepsin B increased markedly in lung homogenates and in bronchoalveolar lavage fluids (BALF) of the mouse model of bleomycin-induced lung fibrosis after 14 days of challenge, and cystatin C was unaffected in BALF of wild-type and cathePSin B-deficient mice.
Journal ArticleDOI

B-cell activating factor regulates IL-1β- and IL-17A-mediated pulmonary fibrosis in mice

TL;DR: The present data, demonstrating a critical role of BAFF by amplifying the IL-17A effect in experimental lung fibrosis, together with increased BAFF levels in the airways of patients with IPF, suggest that BAFF might be a therapeutic target of IPF.